Skip to main content

Table 2 Serum lipid concentration in diabetes patients and controls

From: Elevation of small, dense low density lipoprotein cholesterol—a possible antecedent of atherogenic lipoprotein phenotype in type 2 diabetes patients in Jos, North-Central Nigeria

  Diabetics Controls P-value
Variable (n = 176) (n = 154)  
  Mean ± SD Mean ± SD  
Total Cholesterol (mmol/L) 5.16 ± 1.31 4.35 ± 1.02 < 0.01
Triglycerides (mmol/L) 1.42 ± 0.63 1.00 ± 0.56 < 0.01
HDL-C (mmol/L) 1.21 ± 0.36 1.26 ± 0.40 0.19
LDL-C (mmol/L) 3.31 ± 1.20 2.60 ± 0.91 < 0.01
sdLDL-C (mmol/L) 1.45 ± 0.64 0.80 ± 0.54 < 0.01
lbLDL-C (mmol/L) 1.86 ± 1.09 1.84 ± 0.93 0.85
% LDL-C as sdLDL-C 45.0 ± 17.79 32.0 ± 15.93 < 0.01
TC/HDL-C 4.63 ± 2.40 3.69 ± 1.19 < 0.01
HDL-C/LDL/C 0.41 ± 0.19 0.56 ± 0.36 < 0.01
LDL-C/HDL-C 3.05 ± 2.22 2.29 ± 1.04 < 0.01
  1. Values are expressed as mean ± SD, Unpaired Student’s t-tests, P < 0.05 = significant